当前位置:首页 - 行情中心 - 千红制药(002550) - 财务分析 - 现金流量表

千红制药

(002550)

  

流通市值:75.39亿  总市值:102.51亿
流通股本:9.41亿   总股本:12.80亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,277,800,881.7800,568,355.51390,908,222.871,676,927,387.2
  收到的税费返还166,248.01166,248.01149,770.221,117,030.71
  收到其他与经营活动有关的现金28,823,521.0619,008,921.3810,643,876.2232,864,395.46
  经营活动现金流入小计1,306,790,650.77819,743,524.9401,701,869.311,710,908,813.37
  购买商品、接受劳务支付的现金521,798,617.19339,538,295.46161,923,278.1495,609,925.68
  支付给职工以及为职工支付的现金171,503,922.6123,639,900.8669,782,403.18194,442,795.01
  支付的各项税费111,197,617.867,622,749.5330,760,392.77151,771,394.76
  支付其他与经营活动有关的现金210,943,759.46143,106,397.6167,724,107.01354,375,623.46
  经营活动现金流出小计1,015,443,917.05673,907,343.46330,190,181.061,196,199,738.91
  经营活动产生的现金流量净额291,346,733.72145,836,181.4471,511,688.25514,709,074.46
二、投资活动产生的现金流量:
  收回投资收到的现金---63,390,904.26
  取得投资收益收到的现金15,565,369.034,737,594.541,647,703.336,056,538.38
  处置固定资产、无形资产和其他长期资产收回的现金净额00-13,500,000
  收到的其他与投资活动有关的现金1,260,610,787.43916,001,823.25490,167,089.8202,698,258.36
  投资活动现金流入小计1,276,176,156.46920,739,417.79491,814,793.13285,645,701
  购建固定资产、无形资产和其他长期资产支付的现金76,287,965.8660,708,517.9420,825,106.3590,638,308.88
  投资支付的现金---143,656,422.74
  支付其他与投资活动有关的现金1,341,390,324.21679,853,000343,003,000374,580,000
  投资活动现金流出小计1,417,678,290.07740,561,517.94363,828,106.35608,874,731.62
  投资活动产生的现金流量净额-141,502,133.61180,177,899.85127,986,686.78-323,229,030.62
三、筹资活动产生的现金流量:
  吸收投资收到的现金24,500,000--3,000,000
  其中:子公司吸收少数股东投资收到的现金24,500,000--3,000,000
  取得借款收到的现金---4,690,000
  筹资活动现金流入平衡项目0--0
  筹资活动现金流入小计24,500,000--7,690,000
  偿还债务支付的现金20,000,000600,000-40,103,500
  分配股利、利润或偿付利息支付的现金150,929,352.81150,837,240.79676,735.97151,521,781.68
  支付其他与筹资活动有关的现金00-140,770,172.94
  筹资活动现金流出小计170,929,352.81151,437,240.79676,735.97332,395,454.62
  筹资活动产生的现金流量净额-146,429,352.81-151,437,240.79-676,735.97-324,705,454.62
四、汇率变动对现金及现金等价物的影响-4,075,986.45-1,137,744.46-217,949.66-1,847,664.71
五、现金及现金等价物净增加额-660,739.15173,439,096.04198,603,689.4-135,073,075.49
  加:期初现金及现金等价物余额439,945,400.01439,945,400.01439,945,400.01575,018,475.5
  期末现金及现金等价物余额439,284,660.86613,384,496.05638,549,089.41439,945,400.01
补充资料:
  净利润-249,582,175.18-333,182,546.82
  资产减值准备--51,995,351.1--75,826,178.17
  固定资产和投资性房地产折旧-28,953,674.22-61,597,131.77
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-28,953,674.22-61,597,131.77
  无形资产摊销-1,860,339.43-3,891,548.78
  长期待摊费用摊销-1,927,044.3-4,387,266.47
  固定资产报废损失-29,737.73-38,446.18
  公允价值变动损失--2,768,482.85--2,359,456.78
  财务费用-2,211,042.83-3,234,127.17
  投资损失--5,025,058.69--11,529,730.94
  递延所得税-7,590,764.04-14,776,384.38
  其中:递延所得税资产减少-8,143,009.62-15,270,752.13
    递延所得税负债增加--552,245.58--494,367.75
  存货的减少-68,884,135.02-172,105,649.62
  经营性应收项目的减少--94,972,373.31--12,255,493.78
  经营性应付项目的增加--60,441,465.36-24,090,244.95
  其他----623,412.01
  现金的期末余额-613,384,496.05-439,945,400.01
  减:现金的期初余额-439,945,400.01-575,018,475.5
  现金及现金等价物的净增加额-173,439,096.04--135,073,075.49
公告日期2025-10-302025-08-232025-04-192025-04-19
审计意见(境内)标准无保留意见
TOP↑